Y. Kaya-Yasar Et Al. , "The contribution of the WNT pathway to the therapeutic effects of montelukast in experimental murine airway inflammation induced by ovalbumin and lipopolysaccharide," Drug Development Research , vol.85, no.2, 2024
Kaya-Yasar, Y. Et Al. 2024. The contribution of the WNT pathway to the therapeutic effects of montelukast in experimental murine airway inflammation induced by ovalbumin and lipopolysaccharide. Drug Development Research , vol.85, no.2 .
Kaya-Yasar, Y., Engin, S., Barut, E. N., Inan, C., Saygin, I., Erkoseoglu, I., ... Sezen, S. F.(2024). The contribution of the WNT pathway to the therapeutic effects of montelukast in experimental murine airway inflammation induced by ovalbumin and lipopolysaccharide. Drug Development Research , vol.85, no.2.
Kaya-Yasar, Yesim Et Al. "The contribution of the WNT pathway to the therapeutic effects of montelukast in experimental murine airway inflammation induced by ovalbumin and lipopolysaccharide," Drug Development Research , vol.85, no.2, 2024
Kaya-Yasar, Yesim Et Al. "The contribution of the WNT pathway to the therapeutic effects of montelukast in experimental murine airway inflammation induced by ovalbumin and lipopolysaccharide." Drug Development Research , vol.85, no.2, 2024
Kaya-Yasar, Y. Et Al. (2024) . "The contribution of the WNT pathway to the therapeutic effects of montelukast in experimental murine airway inflammation induced by ovalbumin and lipopolysaccharide." Drug Development Research , vol.85, no.2.
@article{article, author={Yesim Kaya-Yasar Et Al. }, title={The contribution of the WNT pathway to the therapeutic effects of montelukast in experimental murine airway inflammation induced by ovalbumin and lipopolysaccharide}, journal={Drug Development Research}, year=2024}